High Prevalence of Occult Pulmonary Venous Hypertension Revealed by Fluid Challenge in Pulmonary Hypertension
Open accessThe DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
Background—: Determining the cause for pulmonary hypertension is difficult in many patients. Pulmonary arterial hypertension (PAH) is differentiated from pulmonary venous hypertension (PVH) by a wedge pressure (PWP) >15 mm Hg in PVH. Patients undergoing right heart catheterization for evaluation of pulmonary hypertension may be dehydrated and have reduced intravascular volume, potentially leading to a falsely low measurement of PWP and an erroneous diagnosis of PAH. We hypothesized that a fluid challenge during right heart catheterization would identify occult pulmonary venous hypertension (OPVH). Methods and Results—: We reviewed the results of patients undergoing fluid challenge in our pulmonary hypertension database from 2004 to 2011. Baseline hemodynamics were obtained and repeated after infusion of 0.5 L of normal saline for 5 to 10 minutes. Patients were categorized as OPVH if PWP increased to >15 mm Hg after fluid challenge. Baseline hemodynamics in 207 patients met criteria for PAH. After fluid challenge, 46 patients (22.2%) developed a PWP >15 mm Hg and were reclassified as OPVH. Patients with OPVH had a greater increase in PWP compared with patients with PAH, P <0.001, and their demographics and comorbid illnesses were similar to patients with PVH. There were no adverse events related to fluid challenge. Conclusions—: Fluid challenge at the time of right heart catheterization is easily performed, safe, and identifies a large group of patients diagnosed initially with PAH, but for whom OPVH contributes to pulmonary hypertension. These results have implications for therapeutic trials in PAH and support the routine use of fluid challenge during right heart catheterization in patients with risk factors for PVH.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Updated clinical classification of pulmonary hypertension
Simonneau, G., Gatzoulis, M. A., Adatia, I., Celermajer, D., Denton, C., Ghofrani, A., Gomez Sanchez, M. A., Krishna Kumar, R., Landzberg, M., Machado, R. F., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.10.029 · Cited by 4,191 · cited 7×
“In our study, which excluded patients with more than mild LV systolic dysfunction, 84.3% of patients categorized as having PVH, either pre- or postfluid challenge, had a transpulmonary gradient ≥15 mm Hg, ranging from 15 to 51 mm Hg.”
BackgroundInfluentialSelf-citationAuthors/Task Force Members, Galie, N., Hoeper, M. M., Humbert, M., Torbicki, A., Vachiery, J.-L., Barbera, J. A., Beghetti, M., Corris, P., Gaine, S., et al. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp297 · Cited by 3,846
Updated Clinical Classification of Pulmonary Hypertension
Simonneau, G., Robbins, I. M., Beghetti, M., Channick, R. N., Delcroix, M., Denton, C. P., Elliott, C. G., Gaine, S. P., Gladwin, M. T., Jing, Z.-C., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.04.012 · Cited by 2,093
Self-citationPulmonary Hypertension in Heart Failure With Preserved Ejection Fraction
Lam, C. S. P., Roger, V. L., Rodeheffer, R. J., Borlaug, B. A., Enders, F. T., & Redfield, M. M. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.11.051 · Cited by 1,341
Exercise Hemodynamics Enhance Diagnosis of Early Heart Failure With Preserved Ejection Fraction
Borlaug, B. A., Nishimura, R. A., Sorajja, P., Lam, C. S. P., & Redfield, M. M. (2010) · Circulation: Heart Failure · doi:10.1161/circheartfailure.109.930701 · Cited by 1,118 · cited 1×
“A previous study of patients with HFpEF found that simply elevating the legs can help identify those patients who exhibit an increase in PWP with fluid challenge.(16) Whereas this was not performed in our cohort, this should be considered in futures studies of patients with PH.”
ResultScreening, Early Detection, and Diagnosis of Pulmonary Arterial Hypertension
McGoon, M., Gutterman, D., Steen, V., Barst, R., McCrory, D. C., Fortin, T. A., & Loyd, J. E. (2004) · Chest · doi:10.1378/chest.126.1_suppl.14s · Cited by 932
(2006) · Encyclopedic Reference of Molecular Pharmacology · doi:10.1007/3-540-29832-0_1355 · Cited by 885
Califf, R. M., Adams, K. F., McKenna, W. J., Gheorghiade, M., Uretsky, B. F., McNulty, S. E., Darius, H., Schulman, K., Zannad, F., Handberg-Thurmond, E., et al. (1997) · American Heart Journal · doi:10.1016/s0002-8703(97)70105-4 · Cited by 665
Bosentan for Treatment of Inoperable Chronic Thromboembolic Pulmonary Hypertension
Jaïs, X., D'Armini, A. M., Jansa, P., Torbicki, A., Delcroix, M., Ghofrani, H. A., Hoeper, M. M., Lang, I. M., Mayer, E., Pepke-Zaba, J., et al. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.08.059 · Cited by 550
Guazzi, M., Vicenzi, M., Arena, R., & Guazzi, M. D. (2011) · Circulation · doi:10.1161/circulationaha.110.983866 · Cited by 545
Lewis, G. D., Shah, R., Shahzad, K., Camuso, J. M., Pappagianopoulos, P. P., Hung, J., Tawakol, A., Gerszten, R. E., Systrom, D. M., Bloch, K. D., et al. (2007) · Circulation · doi:10.1161/circulationaha.107.716373 · Cited by 515 · cited 1×
“Several of them were treated with phosphodiesterase type 5 inhibitors based on studies showing some benefit, and no deterioration, in patients with elevated postcapillary pressure attributable to either systolic or diastolic LV dysfunction.(21,22) This may be the safest approach in the treatment of patients with combi…”
Diastolic Pulmonary Vascular Pressure Gradient
Gerges, C., Gerges, M., Lang, M. B., Zhang, Y., Jakowitsch, J., Probst, P., Maurer, G., & Lang, I. M. (2013) · Chest · doi:10.1378/chest.12-1653 · Cited by 368 · cited 13×
“In 2004, we began to administer a rapid fluid challenge in patients undergoing RHC as part of the evaluation of PH. Recent studies suggest that fluid challenge is a Original Article © 2013 American Heart Association, Inc. Circ Heart Fail is available at http://circheartfailure.ahajournals.org DOI: 10.1161/CIRCHEARTFAI…”
BackgroundResultInfluentialAnand, I., McMurray, J., Cohn, J. N., Konstam, M. A., Notter, T., Quitzau, K., Ruschitzka, F., & Lüscher, T. F. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16723-8 · Cited by 347
Thenappan, T., Shah, S. J., Gomberg-Maitland, M., Collander, B., Vallakati, A., Shroff, P., & Rich, S. (2011) · Circulation Heart Failure · doi:10.1161/circheartfailure.110.958801 · Cited by 289 · cited 12×
“In 2004, we began to administer a rapid fluid challenge in patients undergoing RHC as part of the evaluation of PH. Recent studies suggest that fluid challenge is a Original Article © 2013 American Heart Association, Inc. Circ Heart Fail is available at http://circheartfailure.ahajournals.org DOI: 10.1161/CIRCHEARTFAI…”
ResultInfluentialHalpern, S. D., & Taichman, D. B. (2009) · Chest · doi:10.1378/chest.08-2784 · Cited by 245
Hemodynamic Responses to Rapid Saline Loading: The Impact of Age, Sex, and Heart Failure
Fujimoto, N., Borlaug, B. A., Lewis, G. D., Hastings, J. L., Shafer, K. M., Bhella, P. S., Carrick-Ranson, G., & Levine, B. D. (2013) · Circulation · doi:10.1161/circulationaha.112.111302 · Cited by 209 · cited 5×
“Our results demonstrate that >20% of patients initially meeting the hemodynamic criteria for PAH develop a PWP >15 mm Hg when given a rapid infusion of 0.5 L NS.”
BackgroundInfluentialMurali, S., Kormos, R. L., Uretsky, B. F., Schechter, D., Reddy, P. S., Denys, B. G., Armitage, J. M., Hardesty, R. L., & Griffith, B. P. (1993) · American Heart Journal · doi:10.1016/0002-8703(93)90704-d · Cited by 208 · cited 1×
“There is no universal definition of combined disease,(17) although previous studies have reported a transpulmonary gradient <12 or <15 mm Hg as indicative of predominantly passive PH resulting from elevated postcapillary pressure.(18,19) It is clear from this study and other recent publications that combined disease i…”
BackgroundAssociation of the metabolic syndrome with pulmonary venous hypertension
Robbins, I. M., Newman, J. H., Johnson, R. F., Hemnes, A. R., Fremont, R. D., Piana, R. N., Zhao, D. X., & Byrne, D. W. (2009) · Chest · doi:10.1378/chest.08-2008 · Cited by 171 · cited 3×
“These variables were chosen based on previous finding of a strong association with PVH.(14) Statistical analyses were performed with using SPSS for Windows (version 20.”
MethodResultSelf-citationBush, C. A., Stang, J. M., Wooley, C. F., & Kilman, J. W. (1977) · Circulation · doi:10.1161/01.cir.56.6.924 · Cited by 171
High prevalence of occult left heart disease in scleroderma-pulmonary hypertension
Fox, B. D., Shimony, A., Langleben, D., Hirsch, A., Rudski, L., Schlesinger, R., Eisenberg, M. J., Joyal, D., Hudson, M., Boutet, K., et al. (2012) · European Respiratory Journal · doi:10.1183/09031936.00091212 · Cited by 162 · cited 5×
“Our results demonstrate that >20% of patients initially meeting the hemodynamic criteria for PAH develop a PWP >15 mm Hg when given a rapid infusion of 0.5 L NS.”
BackgroundInfluentialKaluski, E., Cotter, G., Leitman, M., Milo‐Cotter, O., Krakover, R., Kobrin, I., Moriconi, T., Rainisio, M., Caspi, A., Reizin, L., et al. (2007) · Cardiology · doi:10.1159/000107791 · Cited by 106
Teerlink, J. R., McMurray, J. J. V., Bourge, R. C., Cleland, J. G. F., Cotter, G., Jondeau, G., Krum, H., Metra, M., O’Connor, C. M., Parker, J. D., et al. (2005) · American Heart Journal · doi:10.1016/j.ahj.2005.04.035 · Cited by 70
Cited by
2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
Galiè, N., Humbert, M., Vachiery, J.-L., Gibbs, S., Lang, I., Torbicki, A., Simonneau, G., Peacock, A., Vonk Noordegraaf, A., Beghetti, M., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehv317 · Cited by 6,931
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
Humbert, M., Kovacs, G., Hoeper, M. M., Badagliacca, R., Berger, R. M. F., Brida, M., Carlsen, J., Coats, A. J. S., Escribano-Subias, P., Ferrari, P., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac237 · Cited by 3,975
Galiè, N., Humbert, M., Vachiery, J.-L., Gibbs, S., Lang, I., Torbicki, A., Simonneau, G., Peacock, A., Vonk Noordegraaf, A., Beghetti, M., et al. (2015) · European Respiratory Journal · doi:10.1183/13993003.01032-2015 · Cited by 3,172
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
Humbert, M., Kovacs, G., Hoeper, M. M., Badagliacca, R., Berger, R. M. F., Brida, M., Carlsen, J., Coats, A. J. S., Escribano-Subias, P., Ferrari, P., et al. (2023) · European Respiratory Journal · doi:10.1183/13993003.00879-2022 · Cited by 2,247
Pulmonary arterial hypertension: pathogenesis and clinical management
Thenappan, T., Ormiston, M. L., Ryan, J. J., & Archer, S. L. (2018) · BMJ · doi:10.1136/bmj.j5492 · Cited by 998
Metadata
- Authors
- Robbins, I. M., Hemnes, A. R., Pugh, M. E., Brittain, E. L., Zhao, D. X., Piana, R. N., Fong, P. P., & Newman, J. H.
- Venue
- Circulation: Heart Failure
- Published
- 2014-01
- Volume
- 7
- Issue
- 1
- Pages
- 116-122
- ISSN
- 1941-3289 (ISSN-L)
- 1941-3297
- OpenAlex
- W2148723902
- Cited by
- 182
- References
- 22
- FWCI
- 12.42
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.